GlassScriptPhysician profile
Jeffrey Neil Winter
NPI 1477594547
$6,664.24
in general payments reported to CMS, 2019-2025
41 companies · $496 in 2025
The $496 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,604 · 2020: $605 · 2021: $568 · 2022: $1,580 · 2023: $995 · 2024: $816 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,307.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,288.89 | 2019-2025 | Puraply, Via Matrix, Matrix |
| Lemaitre Vascular, INC. | $831.88 | 2019-2024 | Hydro Lemaitre Valvulotome, Anastoclip Gc 8cm (Medium) |
| W. L. Gore & Associates, INC. | $417.61 | 2019-2022 | |
| Smith+Nephew, INC. | $409.09 | 2019-2025 | Stravix, Grafix Xc, Grafix |
| Janssen Pharmaceuticals, INC | $403.90 | 2019-2022 | |
| Angiodynamics, INC. | $362.88 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Progenacare Global, LLC | $328.70 | 2023 | |
| Kerecis Limited | $243.57 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Silk Road Medical, INC. | $166.99 | 2019-2020 | |
| Polynovo North America LLC | $156.57 | 2022-2023 | |
| Argon Medical Devices, INC. | $156.09 | 2024-2025 | Clot Management, Clot Management |
| Ethicon US, LLC | $155.54 | 2019-2020 | |
| Melinta Therapeutics, LLC | $152.75 | 2019-2023 | Orbactiv, Kimyrsa |
| Endologix LLC | $145.50 | 2024 | Endocross Device, Torus Stent Graft System |
| Mozarc Medical US LLC | $144.39 | 2024-2025 | Palindrome |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $120.55 | 2025 | Symphony Catheter |
| Convatec INC. | $94.04 | 2021-2025 | |
| Triad Life Sciences INC. | $91.17 | 2022 | |
| Boston Scientific Corporation | $87.21 | 2020-2023 | |
| Cardiovascular Systems INC. | $82.07 | 2019 | |
| Tactile Systems Technology INC | $71.14 | 2019-2021 | |
| Pfizer INC. | $70.08 | 2023-2025 | |
| Osiris Therapeutics INC. | $67.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $61.57 | 2020-2025 | Camzyos |
| Molnlycke Health Care US, LLC | $52.84 | 2022 | |
| Solventum Corporation | $52.46 | 2024-2025 | V.A.C. Veraflo, Activ.A.C., Prevena |
| Bioventus LLC | $44.01 | 2022 | |
| Davol INC. | $43.55 | 2025 | Arista |
| Ets Wound Care LLC | $40.36 | 2025 | Mirragen Advanced Wound Matrix |
| Bard Peripheral Vascular, INC. | $38.42 | 2020 | |
| Aroa Biosurgery Incorporated | $35.95 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $34.73 | 2021 | |
| Medtronic Vascular, INC. | $34.34 | 2019-2020 | |
| Inari Medical, INC. | $32.59 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ekos Corporation | $32.29 | 2019 | |
| Medtronic, INC. | $26.53 | 2022-2024 | Venaseal |
| Abbott Laboratories | $21.94 | 2021 | |
| Medline Industries LP | $18.71 | 2021 | |
| Acera Surgical, INC. | $18.13 | 2019 | |
| Hydrofera LLC | $16.30 | 2022 | |
| Omeza LLC | $11.11 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.